Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2005;46:1362-1367
Published online before print October 17, 2005, doi: 10.1161/01.HYP.0000188980.57312.63
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
46/6/1362    most recent
01.HYP.0000188980.57312.63v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jalil, J. E.
Right arrow Articles by Lavandero, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jalil, J. E.
Right arrow Articles by Lavandero, S.
Related Collections
Right arrow ACE/Angiotension receptors

(Hypertension. 2005;46:1362.)
© 2005 American Heart Association, Inc.


Original Articles

Increased Aortic NADPH Oxidase Activity in Rats With Genetically High Angiotensin-Converting Enzyme Levels

Jorge E. Jalil; Alfonso Pérez; María Paz Ocaranza; Jorge Bargetto; Alfonso Galaz; Sergio Lavandero

From the Department of Cardiovascular Diseases, Medical School, P. Universidad Católica de Chile (J.E.J., M.P.O., A.P., J.B., A.G.), and Departamento de Bioquímica and Biología Molecular, Facultad Ciencias Químicas y Farmacéuticas (J.B., A.G., I.G., S.L.), ICBM, Facultad de Medicina (S.L.) and Centro FONDAP Estudios Moleculares de la Célula (S.L.), Universidad de Chile, Santiago.

Correspondence to Dr Jorge Jalil, Departamento de Enfermedades Cardiovasculares, Escuela de Medicina, P. Universidad Católica de Chile, Lira 85, Piso 2, Santiago, Chile. E-mail jjalil{at}med.puc.cl or Dr Sergio Lavandero, Departamento Bioquímica and Biología Molecular, Facultad Ciencias Químicas y Farmacéuticas, Universidad de Chile, Olivos 1007, Santiago 664-0750, Chile. E-mail slavander@uchile.cl

In humans and rats, angiotensin I–converting enzyme activity is significantly determined by a gene polymorphism. Homozygous Brown Norway rats have higher plasma angiotensin I–converting enzyme activity and circulating angiotensin II (Ang II) levels than Lewis rats. Because Ang II induces NAD(P)H oxidase activation, we hypothesized here that Brown Norway rats have higher vascular NAD(P)H oxidase activity and superoxide anion production than Lewis rats. Homozygous Brown Norway (n=15) and Lewis (n=13) male rats were used. Plasma angiotensin I–converting enzyme activity (by fluorimetry), Ang II levels (by high-performance liquid chromatography and radioimmunoassay), and aortic NAD(P)H oxidase activity, as well as superoxide anion production (by chemiluminescence with lucigenin) were measured. Plasma angiotensin I–converting enzyme activity and Ang II levels were 100% higher in Brown Norway rats than in Lewis rats (P<0.05). Aortic angiotensin I– converting enzyme, but not Ang II, was elevated (P<0.05). Aortic superoxide anion production and NAD(P)H oxidase activity were 300% and 260% higher in Brown Norway than in Lewis rats, respectively (P<0.05), which was not observed in Brown Norway rats treated with candesartan (10 mg/kg per day for 7 days). Endothelial NO synthase activity in the aorta from Brown Norway rats was significantly lower than in Lewis rats. However, inducible NO synthase activity and both endothelial NO synthase and inducible NO synthase mRNA and protein levels were similar in both genotypes. In summary, Brown Norway rats have higher vascular NAD(P)H oxidase activity and superoxide anion production than Lewis rats, suggesting the presence of a higher level of vascular oxidative stress in rats with genetically higher angiotensin I–converting enzyme levels. This effect is mediated through the angiotensin I receptor.


Key Words: angiotensin-converting enzyme • polymorphism • nitric oxide




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Whaley-Connell, J. Habibi, S. A. Cooper, V. G. DeMarco, M. R. Hayden, C. S. Stump, D. Link, C. M. Ferrario, and J. R. Sowers
Effect of renin inhibition and AT1R blockade on myocardial remodeling in the transgenic Ren2 rat
Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E103 - E109.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
W. J. Welch
Angiotensin II-Dependent Superoxide: Effects on Hypertension and Vascular Dysfunction
Hypertension, July 1, 2008; 52(1): 51 - 56.
[Full Text] [PDF]


Home page
HypertensionHome page
P. Rivera, M. P. Ocaranza, S. Lavandero, and J. E. Jalil
Rho Kinase Activation and Gene Expression Related to Vascular Remodeling in Normotensive Rats With High Angiotensin I Converting Enzyme Levels
Hypertension, October 1, 2007; 50(4): 792 - 798.
[Abstract] [Full Text] [PDF]